0 mmol/mL

DRUG2 trials

Sponsors

Hopital Fondation Adolphe De Rothschild, Centre Hospitalier Universitaire De Saint Etienne

Conditions

Ischemic stroke with Large Corehematology

Phase 2

Glenzocimab in Anterior stroke with Large Ischemic Core eligible for Endovascular therapy

Not yet recruitingCTIS2023-509615-92-00

Hopital Fondation Adolphe De RothschildIschemic stroke with Large Core

Target: 304Updated: 2024-05-22

Phase 4

Temporal characterization of Extracellular Vesicles during cellular therapy using CAR-T cells and during the occurrence of Immune effector Cell-Associated Neurotoxicity Syndrome : the VESICANS study

RecruitingCTIS2024-515328-35-00

Centre Hospitalier Universitaire De Saint Etiennehematology

Start: 2025-07-02Target: 60Updated: 2025-04-17